What type of study is this?

August 19, 2025Panacea Journal of Medical SciencesOpen Access

Study of adverse drug reactions (ADR’S) requiring change in anti-tubercular regimen in multi-drug resistant tuberculosis (MDR-TB) patients in a tertiary healthcare centre

View Full Paper

Ask AI

Bookmark

Severe adverse drug reactions commonly necessitate changes in the anti-tubercular regimen, leading to treatment non-adherence.
Out of 172 MDR-TB patients, 60 exhibited adverse drug reactions requiring regimen alterations, with females representing 63.3%.
Analysis employed Line Probe Assay and Drug Sensitivity Testing to guide treatment modifications for affected patients.
Findings highlight the need for monitoring adverse reactions in MDR-TB treatment to improve drug compliance and outcomes.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Observational study finds 34.8% of MDR-TB patients require regimen changes due to adverse drug reactions, indicating significant treatment challenges.

Cite This Study

Unni et al. (2025) studied this question.

synapsesocial.com/papers/68af4760ad7bf08b1ead4613 https://doi.org/10.18231/pjms.v.15.i.2.289-291

View Full Paper

Ask AI

Bookmark

Implication

Observational study finds 34.8% of MDR-TB patients require regimen changes due to adverse drug reactions, indicating significant treatment challenges.

Study of adverse drug reactions (ADR’S) requiring change in anti-tubercular regimen in multi-drug resistant tuberculosis (MDR-TB) patients in a tertiary healthcare centre

Key Points

Discussion

Implication

Cite This Study

Study of adverse drug reactions (ADR’S) requiring change in anti-tubercular regimen in multi-drug resistant tuberculosis (MDR-TB) patients in a tertiary healthcare centre

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider